Financials
- Market Capitalization 1.9 B
- Employee 524
- Founded 2008
- CEO Bahija Jallal
- Website www.immunocore.com
- Headquarter United Kingdom
- FIGI BBG00YYCXFB9
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-83.55
Relación precio/flujo de caja
3.77
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2027 | MRVI Maravai LifeSciences Holdings, Inc. - Class A common stock | 7.31 USD | -4.32% | -18.78% | +10.76% | +205.86% | 1.90 B USD | ||
| 2028 | NBTX Nanobiotix S.A. - ADSs | 39.48 USD | -2.85% | -4.89% | +5.08% | +376.24% | 1.91 B USD | ||
| 2035 | TSHA Taysha Gene Therapies, Inc. - Common Stock | 5.70 USD | +0.18% | -8.06% | -3.23% | +96.55% | 1.86 B USD | ||
| 2062 | SNDX Syndax Pharmaceuticals, Inc. - Common Stock | 20.10 USD | +4.20% | +0.90% | +5.73% | +21.82% | 1.79 B USD |